Frank Thomas
2021
In 2021, Frank Thomas earned a total compensation of $2M as President & COO at Orchard Therapeutics plc, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $235,000 |
|---|---|
| Option Awards | $1,257,233 |
| Salary | $470,000 |
| Other | $11,600 |
| Total | $1,973,833 |
Thomas received $1.3M in option awards, accounting for 64% of the total pay in 2021.
Thomas also received $235K in non-equity incentive plan, $470K in salary and $11.6K in other compensation.
Rankings
In 2021, Frank Thomas' compensation ranked 6,097th out of 12,415 executives tracked by ExecPay. In other words, Thomas earned more than 50.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,097 out of 12,415 | 51st |
Division Manufacturing | 2,577 out of 5,505 | 53rd |
Major group Chemicals And Allied Products | 1,127 out of 2,375 | 53rd |
Industry group Drugs | 1,004 out of 2,096 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 243 out of 449 | 46th |
Source: SEC filing on April 27, 2022.
Thomas' colleagues
We found one more compensation record of an executive who worked with Frank Thomas at Orchard Therapeutics plc in 2021.
2021
Bobby Gaspar
Orchard Therapeutics plc